References
- WHO. Response to the Ebola outbreak. Situation Report, January 21, 2015. http://www.who.int/csr/disease/ebola/situation-reports/en/. Access: January 27, 2015
- Rezza G. Ebola: when a nightmare becomes reality. Ann Ist Super Sanità 2014; 50:307-8; PMID:25522067; http://dx.doi.org/10.4415/ANN_14_04_01
- Sullivan NJ, Sanchez A, Rollin PE, Nabel GJ. Development of a preventive vaccine for Ebola virus infection in primates. Nature 2000; 408:605-9; PMID:11117750; http://dx.doi.org/10.1038/35046108
- Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, et al. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine 2010; 29:304-13; PMID:21034824; http://dx.doi.org/10.1016/j.vaccine.2010.10.037
- Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.org/10.1128/CVI.00131-10
- Ledgerwood JE, DeZure AD, Stanley DA, Novik L, Enama ME, Berkowitz NM, Hu Z, Joshi G, Ploquin A, Sitar S, et al. Chimpanzee adenovirus vector Ebola vaccine-Preliminary report. N Engl J Med 2014; DOI: 10.1056/NEJMoa1410863; PMID:25426834
- Sullivan NJ, Martin JE, Graham BS, Nabel GJ. Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by animal rule. Nat Rev Microbiol 2009; 7:684; http://dx.doi.org/10.1038/nrmicro2129
- Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC, Hensley L, Ammendola V, Abbate A, Grazioli F, et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus chellange. Nat Med 2014 Oct 20(10): 1126-29; Epub 2014 Sep 7; PMID:25194571; http://dx.doi.org/10.1038/nm.3702
- Rampling T, Ewer K, Bowyer G, Wright D, Imoukhuede EB, Payne R, Hartnell F, Gibani M, Bliss C, Minhinnick A, et al. A monovalent chimpanzee adenovirus Ebola vaccine-Preliminary report. N Engl J Med 2015; PMID:25629663; http://dx.doi.org/10.1056/NEJMoa1411627
- Bausch DG. One step closer to an Ebola virus vaccine. N Engl J Med 2014; PMID:25426836; http://dx.doi.org/10.1056/NEJMe141305
- Kibuuka H, Berkowitz NM, Millard M, Enama ME, Tindikahwa A, Sekiziyivu AB, Costner P, Sitar S, Glover D, Hu Z, et al. Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: phase 1b, randomized, double-blind, placebo-controlled clinical trial. Lancet 2014; PMID:25540891; http://dx.doi.org/10.1016/50140-6736(14)62385-0
- Sridhar S. Ebola and Marburg vaccines for Africa: one step closer. Lancet 2014; PMID:25540890; http://dx.doi.org/10.1016/S0140-6736(14)62445-4
- WHO. Experimental Ebola vaccines. Ebola situation assessment – 1 October 2014. http://www.who.int/mediacentre/news/ebola/01-october-2014/en/index2.html. Access: 08/01/2015
- Johnson & Johnson. Johnson & johnson announces major commitment to speed Ebola vaccine development and significantly Expand Production. http://www.jnj.com/news/all/Johnson-Johnson-Announces-Major-Commitment-to-Speed-Ebola-Vaccine-Development-and-Significantly-Expand-Production. Last update 1–12–2015)
- Muhammadi D. Ebola vaccine trials back on track. Lancet 2015; 385:214-5; PMID:25601786; http://dx.doi.org/10.1016/S0140-6736(15)60035-6
- Marzi A, Feldman H. Ebola virus vaccines: an overview of current approaches. Expert Rev Vaccines 2014; 13:521-31; PMID:24575870; http://dx.doi.org/10.1586/14760584.2014.885841
- Cohen J. Ebola vaccine: little and late. Science 204; 345:1441-2; PMID:25237082; http://dx.doi.org/10.1126/science.345.6203.1441
- Kanapathipillai R, Rastrepo AMH, Fast P, Wood D, Dye C, Kieny MP, Moorthy V. Ebola vaccine – an urgent priority. N Engl J Med 2014; 371:2249-51; PMID:25289888; http://dx.doi.org/10.1056/NEJMp1412166
- Tully CM, Lambe T, Gilbert SC, Hill AVS. Emergency ebola response: a new approach to the rapid design and development of vaccines against emerging diseases. Lancet 2015. http://dx.doi.org/10.1016/S1473-3099(14)71071-0; PMID:25595637
- Cohen J. Ebola vaccines racing forward at record pace. Science 2014; 345:1228-9; PMID:25214582; http://dx.doi.org/10.1126/science.345.6202.1228
- Cohen J, Kupferschmidt. Ebola vaccine trials raise ethical issues. Science 2014; 346:289-90; PMID:25324364; http://dx.doi.org/10.1126/science.346.6207.289
- CIDRAP. Wellcome Trust. Fast-track development of Ebola vaccines. January 12, 2015. http://www.cidrap.umn.edu/news-perspective/2015/01/report-maps-complex-challenges-ebola-vaccine-efforts
- Cooper CL, Bavari S. A race for an Ebola vaccine: promises and obstacles. Trends in Microbiology 2014; 23:65-6. PMID:25535021; http://dx.doi.org/10.1016/j.tim.2014.12.005
- Woodall J, Feldman R. Ebola update 16. ProMED-mail, January 17, 2015. http://www.promedmail.org/
- Lee BY, Moss WJ, Privor-Dumm L, Constenla DO, Knoll MD, O'Brien KL. Is the world ready for an Ebola vaccine? Lancet 2015; 385:203-4; PMID:25706696; http://dx.doi.org/10.1016/S0140-6736(14)62398-9